With 400+ custom Next-Generation Sequencing (NGS) panels delivered to 200+ research institutions, testing labs, and biopharma companies, Paragon Genomics strives to be your NGS assay partner of choice. 

Custom Panel Consultation
Ready-to-Use NGS Assays

Technology

CleanPlex for Targeted DNA or RNA Seq

  • 3-5 hour workflow
  • Patented PCR background cleaning
  • Low DNA/RNA input

Learn More >

CleanPlex UMI for cfDNA Liquid Biopsy

  • Unique molecular barcoding chemistry
  • Fast workflow
  • Ultra sensitivity

Learn More >

OmniFusion for RNA Gene Fusion Detection

  • 6-hour workflow
  • Built on single primer chemistry
  • Detect novel gene fusions

Learn More >

CleanPlex for Single Cell DNA or RNA Seq

  • Single cell input
  • Single cell variant calling
  • Skip Whole Genome Amplification

Inquire >

COVID-19 Resources

“I was very impressed by how well the CleanPlex SARS-CoV-2 panel worked when we evaluated it back in March. Working with Paragon Genomics, we were able to leverage the panel to quickly launch a SARS-CoV-2 whole-genome sequencing assay and used it effectively for a number of genomic epidemiology studies. As a human geneticist and informaticist, I am also excited about the availability of the CleanPlex ACE2/TMPRSS2 germline + eQTL panel.”

Xiaowu Gai, PhD, Director of Bioinformatics, Children's Hospital Los Angeles

Application

Solid Tumor Profiling

Tumor profiling using NGS targeted sequencing

Infectious Disease

infectious disease research and testing, pathogen detection via NGS targeted amplicon sequencing

cfDNA Analysis

cancer liquid biopsy via NGS targeted sequencing

CTC Analysis

single cell circulating tumor cells analysis via NGS targeted sequencing

Genetic Disorders

inherited diseases and genetic disorders research via NGS targeted amplicon sequencing

Pharmacogenomics

pharmacogenomics or pharmacogenetics research and testing via NGS targeted amplicon sequencing

CRISPR

crispr editing confirmation and off-target evaluation via NGS targeted amplicon sequencing

Molecular Breeding

agrigenomics and molecular breeding via NGS targeted amplicon sequencing

Customer Testimonials

I was very impressed by how well the CleanPlex SARS-CoV-2 panel worked

“I was very impressed by how well the CleanPlex SARS-CoV-2 panel worked when we evaluated it back in March. Working with Paragon Genomics, we were able to leverage the panel to quickly launch a SARS-CoV-2 whole-genome sequencing assay and used it effectively for a number of genomic epidemiology studies. As a human geneticist and informaticist, I am also excited about the availability of the CleanPlex ACE2/TMPRSS2 germline + eQTL panel. We have sequenced thousands of positive COVID 19 samples, which revealed a tremendous amount of viral genetic diversity. It is therefore most interesting now to study the host genetic variants, especially in the ACE2 and TMPRSS2 genes that are the two most essential genes for SARS-CoV-2 infection. The interplay of human host genetic variants in these genes, along with the SARS-CoV-2 mutations and haplotypes, may well determine how severe the infection is and the resulting clinical phenotypes.”

Xiaowu Gai, PhD, Director of Bioinformatics, Children's Hospital Los Angeles

Affordable and easy-to-use product

“When we decided to choose a target enrichment platform, we had several choices and I am delighted that we chose Paragon Genomics. Paragon Genomics has enabled us to move our sequencing in-house with an affordable and easy-to-use product. They assisted us every step along the way from choosing the amplicons, to guiding us through library preparation to assisting with analysis. I strongly recommend their CleanPlex® amplicon-based targeted sequencing approach and could not be happier with their product.”

Elliot Stieglitz, MD, Assistant Professor, University of California San Francisco

Complete viral genomes from clinical samples with low viral content

“We’re using Paragon’s CleanPlex and CleanPlex UMI technologies to sequence RNA viruses. These technologies enable us to rapidly and cost-effectively obtain complete viral genomes from clinical samples with low viral content. Further analyses of viral genomes, including the identification of minor variants, elucidates viral diversity and evolution. Paragon has enthusiastically worked with us to tackle this new application; they have diligently designed panels to our specifications, meeting with us frequently to optimize the design.”

Aaron Lin, PhD; Erica Normandin; Kim Lagerborg, The Broad Institute of MIT and Harvard

Great PCR uniformity and on-target rate

“Paragon Genomics designed a high-quality NGS custom panel for us within two weeks. Its CleanPlex® targeted library technology is fast and easy to use with great PCR uniformity and on-target rate. We are very satisfied by CleanPlex product performance and the superb technical and customer support provided by the Company.”

Chongjian Chen, PhD, CEO, Annoroad

Robust and work directly from the start

“As a service provider and distributor company, it is crucial for us to fulfill inquiries coming from our customer in a fast and reliable manner. Paragon Genomics’ custom design and production pipeline has shown itself very useful to expand our portfolio and services in a very short time. Their CleanPlex® assays are robust and work directly from the start with a uniform coverage distribution and the ability to design single gene or small gene panels as well as larger panels makes CleanPlex a flexible tool.”

Damla Erdogan, Business Development Manager, Gen Era Diagnostics

A ‘future proof method’ and a ‘one and done’ approach

“We are looking for a ‘future proof method’, a better way to do high throughput screening at a species level diagnosis. Paragon Genomics has developed a rapid 2.5-hour library preparation allowing multi-gene methodology, letting us look at lots of unique loci across multiple genomes. It offers a ‘one and done’ approach instead of many different disconnected experiments.”

Scott Geib, PhD, Research Entomologist, USDA-ARS

Who’s Choosing CleanPlex NGS Panels

Researchers and assay developers from over 200 research, testing, IVD and biopharma organizations globally are using CleanPlex for their targeted sequencing applications